Showing results (351-360 of 688) with videos related to
Sort By:
Pageof 69
JMIR Research Protocols|April 7, 2025
Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective Observational StudyDeborah A Hall, Josh M Shulman, Andrew Singleton, et al.Digestive Diseases and Sciences|March 17, 2024
Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada TrialJesse Siffledeen, Sunny Singh, Scott M Shulman, et al.Stereotactic and Functional Neurosurgery|December 22, 2000
Electromyography during stereotactic pallidotomy for Parkinson's diseaseH J Landy, W J Weiner, B Calancie, et al.Journal of Medicinal Chemistry|June 9, 1995
Comparison of the protonation of isophosphoramide mustard and phosphoramide mustardK K Millis, M E Colvin, E M Shulman-Roskes, et al.Neurology|August 9, 2006
When do patients with Parkinson disease disclose their diagnosis?S Haines, H Chen, K E Anderson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 6, 1998
Asymmetric predominantly ipsilateral blepharospasm and contralateral parkinsonism in an elderly patient with a right mesencephalic cystC Singer, N J Schatz, B Bowen, et al.Genes|September 29, 2019
A Portal to Visualize Transcriptome Profiles in Mouse Models of Neurological DisordersRami Al-Ouran, Ying-Wooi Wan, Carl Grant Mangleburg, et al.Aging Cell|November 30, 2011
The CETP I405V polymorphism is associated with an increased risk of Alzheimer's diseaseLei Yu, Joshua M Shulman, Lori Chibnik, et al.The American Journal of Pathology|August 1, 1982
Acute and chronic graft-versus-host disease in dogs given hemopoietic grafts from DLA-nonidentical littermates. Two distinct syndromesK Atkinson, H M Shulman, H J Deeg, et al.Archives of Neurology|January 13, 2010
The clinically important difference on the unified Parkinson's disease rating scaleLisa M Shulman, Ann L Gruber-Baldini, Karen E Anderson, et al.Pageof 69